Concepedia

Author

P J Bugelskil

Trudeau Institute

Also Known As

P J Bugelskil

1

Publications

72

Citations

1

H-Index

0

Concepts

All Affiliations

Trudeau Institute
PJ

About

P J Bugelskil is an author at Trudeau Institute.

P J Bugelskil

×

1

Publications

72

Citations

1

H-Index

YearCitations

Preclinical development of keliximab, a Primatized™ anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies

P J Bugelskil, D J Herzykl, Sabine Rehm,

Human & Experimental Toxicology

2000

72

Page 1